Cite
Agarwal S, Saini S, Parashar D, et al. The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. Oncoimmunology. 2013;2(5):e24270doi: 10.4161/onci.24270.
Agarwal, S., Saini, S., Parashar, D., Verma, A., Sinha, A., Jagadish, N., Batra, A., Suri, S., Gupta, A., Ansari, A. S., Lohiya, N. K., & Suri, A. (2013). The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. Oncoimmunology, 2(5), e24270. https://doi.org/10.4161/onci.24270
Agarwal, Sumit, et al. "The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma." Oncoimmunology vol. 2,5 (2013): e24270. doi: https://doi.org/10.4161/onci.24270
Agarwal S, Saini S, Parashar D, Verma A, Sinha A, Jagadish N, Batra A, Suri S, Gupta A, Ansari AS, Lohiya NK, Suri A. The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. Oncoimmunology. 2013 May 01;2(5):e24270. doi: 10.4161/onci.24270. Epub 2013 Apr 01. PMID: 23762804; PMCID: PMC3667910.
Copy
Download .nbib